AT
GILD icon

American Trust’s Gilead Sciences GILD Stock Holding History

American Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Sell
1,913
-613
-24% -$85.8K 0.02% 247
2025
Q4 		$310K Buy
2,526
+620
+33% +$75.3K 0.03% 232
2025
Q3 		$212K Buy
+1,906
New +$217K 0.02% 305
2025
Q1 		– Sell
-2,369
Closed -$219K – 182
2024
Q4 		$219K Sell
2,369
-24,690
-91% -$2.22M 0.02% 288
2024
Q3 		$2.27M Sell
27,059
-6,167
-19% -$471K 0.19% 73
2024
Q2 		$2.28M Sell
33,226
-3,205
-9% -$214K 0.19% 75
2024
Q1 		$2.67M Buy
36,431
+15
+0% +$1.15K 0.22% 76
2023
Q4 		$2.95M Sell
36,416
-1,013
-3% -$78.8K 0.22% 73
2023
Q3 		$2.8M Buy
37,429
+34,112
+1,028% +$2.62M 0.22% 76
2023
Q2 		$256K Sell
3,317
-170
-5% -$13.6K 0.02% 342
2023
Q1 		$289K Buy
+3,487
New +$289K 0.02% 317

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Trust's GILD Position: Q1 2026 in Review

American Trust reduced its Gilead Sciences (GILD) stake by 24% in Q1 2026, selling an estimated $85.8K and leaving 1,913 shares worth $267K. The position accounts for 0.02% of the portfolio, ranked #247.

American Trust first reported a position in GILD in Q1 2023 and has held it in 11 quarters since. The position peaked at $2.95M in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • American Trust held 1,913 shares of Gilead Sciences worth $267K as of Q1 2026.
  • American Trust sold 613 Gilead Sciences shares in Q1 2026, an estimated $85.8K.
  • Gilead Sciences made up 0.02% of American Trust's portfolio in Q1 2026, its #247 holding.
  • American Trust first reported a position in Gilead Sciences in Q1 2023 and has held it in 11 quarters since.
  • American Trust's Gilead Sciences position peaked at $2.95M in Q4 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.